Hypertensive renal disease

Disease

2 papers study it2 more mention it2 findings

  • Humans1
  • Animals1

Effects

1

Mortality

upin humans1

1 study
  1. Hypertensive renal disease increases mortality in humans (APC 9.75% (95% CI: 7.87–11.67), AAMR from 5.28 to 29.60).

    “From 1999 to 2020, a total of 618,157 deaths occurred from HRD in adults. AAMR started from 5.28 in 1999 and ended at 29.60 in 2020 (Total AAMR: 12.93) [APC: 9.75 (95% CI: 7.87–11.67)].”

    Humans1999 to 2020n = 618,157

    Unseen and Unstoppable: The Burden of Hypertensive Renal Disease in the U.S. - A 22-Year Mortality Analysis (1999–2020)

    AHA Scientific Sessions 2025 abstract

Upstream

1

ATP1A1

downin rats1

1 study
  1. ATP1A1 decreases hypertensive renal disease in rats.

    “Transgenic Dahl S rats exhibited less salt-sensitive hypertension, less hypertensive renal disease, and longer life span when compared with non-transgenic Dahl S controls.”

    Animalsin transgenic Dahl S rats bearing Dahl R wild-type alpha1 Na,K-ATPase cDNA

    The alpha1 Na,K-ATPase gene is a susceptibility hypertension gene in the Dahl salt-sensitiveHSD rat

    The Journal of clinical investigation

More on ATP1A1

Latest

Nov 2025: 1Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 01 paper in 12 months